Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 1, 2008, Pages 71-77

  Rotimi, Vincent O ^a   Jamal, Wafaa ^a   Pal, Tibor ^b   Sonnevend, Agnes ^b   Dimitrov, Tsonyo S ^c   Albert, M John ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c Infectious Diseases Hospital Kuwait   (Kuwait)

Author keywords

Ciprofloxacin; Kuwait; Multidrug resistance; Reduced susceptibility; Salmonella spp.; UAE

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; KUWAIT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; SALMONELLA ENTERICA; SALMONELLOSIS; UNITED ARAB EMIRATES;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; KUWAIT; MICROBIAL SENSITIVITY TESTS; SALMONELLA; SALMONELLA INFECTIONS; UNITED ARAB EMIRATES;

EID: 36849075270     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.07.007     Document Type: Article

References (33)

1. Al-Tawfiq J.A. Antimicrobial susceptibility of Salmonella typhi and non-typhi in a hospital in eastern Saudi Arabia. J. Chemother. 19 (2007) 62-65
2. Biedenbach D.J., Toleman M., Timothy R., Walsh T.R., and Jones R.N. Analysis of Salmonella spp. with resistance to extended spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from SYNTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis. 54 (2006) 13-21
3. Cebrián L., Rodriguez J.C., Escribano I., and Royo G. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms. Chemother 51 (2005) 40-43
4. Clinical and Laboratory Standards Institute. Performance Standard for Antimicrobial Susceptibility Testing: Document M100-S15 (2005), CLSI, Wayne, PA
5. Dashti A.A. Increasing incidence of Salmonella typhi with reduced susceptibility to ciprofloxacin. XIX International ISTH Congress; Abstract no. 902. J. Thromb. Haemost. 1 Suppl 1 (2003) 766
6. Dimitrov T.S., Udo E.E., Verghese T., Emara M., and Al-Saleh A. Plasmid-mediated high level ceftriaxone resistance in Salmonella enterica serotype typhimurium isolate. Med. Princ. Pract. 15 (2006) 145-148
7. Dunne E.F., Fey P.D., Kludt P., Reporter R., Mostashari F., Shillam P., Wicklund J., Miller C., Holland B., Stamey K., Barrett T.J., Rasheed J.K., Tenover F.C., Ribot E.M., and Anqulo F.J. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 284 (2000) 3151-3156
8. Hakanen A., Kotilainen P., Jalava J., Siitonen A., and Huovinen P. Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. J. Clin. Microbiol. 37 (1999) 5372-5377
9. Hakanen A., Kotilainen P., Huovinen P., Helenius H., and Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travellers returning from Southeast Asia. Emerg. Infect. Dis. 7 (2001) 996-1003
10. Hakanen A.J., Kotilainen P., Pitkanen S., Huikko S., Siitonen A., and Huovinen P. Reduction of fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J. Antimicrob. Chemother. 57 (2006) 569-572
11. Hammami A., Arlet G., Ben Redjeb S., Grimont F., Ben Hassen A., Rekik A., and Philippon A. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 B-lactamase. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 641-646
12. Helms M., Vastrup P., Gerner-Smidt P., and Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg. Infect. Dis. 8 (2002) 490-495
13. Hohmann E.L. Non-typhoidal salmonellosis. Clin. Infect. Dis. 32 (2001) 263-269
14. Jamal W.Y., Pal T., Rotimi V.O., and Chugh T.D. Serogroups and antimicrobial susceptibility of clinical isolates of Salmonella species from a teaching hospital in Kuwait. J. Diarrhoeal Dis. Res. 16 (1998) 180-186
15. Koeck J.L., Ariet G., Phillippon A., Basmaciogullari S., Thien H.V., Buisson T., and Cavallo J.D. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152 (1997) 255-260
16. Lyytikainen O., Koort J., Ward L., Schildt R., Ruutu P., Japisson E., Timonen M., and Siitoner A. Molecular epidemiology of an outbreak caused by Salmonella enterica server Newport in Finland and United Kingdom. Epidemiol. Infect. 124 (2000) 185-192
17. Martin L.J., Fyfe M., Dore K., Buxton J.A., Henry B., Meddleton D., Ahmed R., Jamieson F., Ciebin B., McEwen S.A., Wilson J.B., and Multi-provincial Salmonella typhimurium case-control study steering committee. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J. Infect. Dis. 189 (2004) 377-384
18. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., Griffin P.M., and Tauxe R.V. Food-related illness and death in the United States. Emerg. Infect. Dis. 5 (1999) 607-625
19. Molbak K., Baggesen D.L., Aarestrup F.M., Ebbesen J.M., Engberg J., Frydendahl K., Gerner-Smidt P., Pelersen A.M., and Wegener H.C. An outbreak of multi-drug resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N. Engl. J. Med. 341 (1999) 1420-1425
20. Morosini M.I., Blazquez J., Negri M.C., Canton R., Loza E., and Baquero F. Characterization of a nosocomial outbreak involving an epidemic plasmid encoding for TEM-27 in Salmonella enterica subspecies enterica serotype othmarschen. J. Infect. Dis. 174 (1996) 1015-1020
21. Murray A., Coia J.E., Mather H., and Brown D.J. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. J. Antimicrob. Chemother. 56 (2005) 110-114
22. Panthorta B.R., Saxena A.K., and Al-Ghamdi A.M. Emerging nalidixic and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease. Ann. Saudi Med. 24 (2004) 332-336
23. Piddock L.J., Griggs D.J., Hall M.C., and Jin Y.F. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob. Agents Chemother. 37 (1993) 662-666
24. Sivapalasingam S., Barrett K., Kimura A., Van Duyne S., De Witt W., Ying M., Frisch A., Phan Q., Gould E., Shillam P., Reddy V., Cooper T., Hoekstra M., Higgins C., Sanders J.P., Tauxe R.V., and Slutsker L. A multistate outbreak of Salmonella enterica serotype Newport infection linked to mango consumption: impact of water-dip disinfestation technology. Clin. Infect. Dis. 37 (2003) 1585-1590
25. Su L.H., Chiu C.H., Chu C., Wang M.H., Chia J.H., and Wu T.L. In-vitro acquisition of ceftriaxone resistance in Salmonella enterica serotype antum. Antimicrob. Agents Chemother. 47 (2003) 563-567
26. Su L.H., Wu T.L., Chia J.H., Chu C., Kuo A.J., and Chiu C.H. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 55 (2005) 846-852
27. Threlfall E.J. Antimicrobial drug resistance in salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol. Rev. 26 (2002) 141-148
28. Threlfall E.J., Ward L.R., Skinner J.A., and Rowe B. Increase in multiple antibiotic resistance in non-typhoidal salmonellas from humans in England and Wales: comparison of data for 1994 and 1996. Microbiol. Drug Res. 3 (1997) 263-266
29. Varma J.K., Molbak K., Barrett T.J., Beebe J.L., Jones T.F., Radatsky-Her T., et al. Antimicrobial-resistant nontyphoidal Salmonella associated with excess bloodstream infections and hospitalisations. J. Infect. Dis. 191 (2005) 554-561
30. Wedel S.D., Bender J.B., Leano F.T., Boxrud D.J., Hedberg C., and Smith K. Antimicrobial-drug susceptibility of human and animal Salmonella typhimurium, Minnesota, 1997-2003. Emerg. Infect. Dis. 11 (2005) 1899-1906
31. WHO Progress Report (2005). http://www.who.int/foodsafety
32. Winokur P.L., Vonstein D.L., Hoffman L.J., Uhlenhopp E.K., and Doern G.V. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food, animals and humans. Antimicrob. Agents Chemother. 45 (2001) 2716-2722
33. Zhang R., Eggleston K., Zechhauser R., and Rotimi V.O. Globalization and the antibiotic resistance problem: evidence from China, Kuwait and United States. Globalization Health 2 (2006) 6 (Open access)